Fighting HIV in the Ivory Coast: WHOs New Guidelines Benefit FewSo, the World Health Organization is advising that all people with HIV in the Ivory Coast take ARVs if they have an HIV-negative partner. That sounds good right? Well, considering the shaky disclosure practices between couples in the country, these new TaSP guidelines mean only 12% of the population will ultimately qualify…

Fighting HIV in the Ivory Coast: WHOs New Guidelines Benefit Few

So, the World Health Organization is advising that all people with HIV in the Ivory Coast take ARVs if they have an HIV-negative partner. That sounds good right? Well, considering the shaky disclosure practices between couples in the country, these new TaSP guidelines mean only 12% of the population will ultimately qualify…

After ramping up routine HIV screenings for all patients admitted to the hospital over the last few years, Canadian researchers have proved that doctors can hone in on more than double the number of HIV cases they usually find, both in terms of acute infections and late presenters.

The study’s conclusion asks: Does “risk assessment” by doctors stigmatize testing? Shouldn’t we just start screening everyone?

Providing TaSP When Stuck Between a Rock & a Hard Place

In the absence of universal antiretroviral (ARV) treatment, should we prioritize on providing HIV meds to the main drivers of the epidemic first before making them available to the rest of the population? This new theory from aidsmap says yes.

If countries followed the idea, it would mean injection drug users and female sex workers would be treated before all other at-risk groups.

POZ Exclusive: Jetsons-Era HIV Care and PreventionLet’s take a quick look over some futuristic highlights from this year’s Conference on Retroviruses and Opportunistic Infections (CROI):

Risk of Transmitting HIV With Undetectable Viral Load = “Close to Zero”
There Are Big Benefits To Very Early Treatment
Genetically Modified Immune Cells May Be Possible
Possibiltiy of Long-Term Injectable ARVs?
Attachment Inhibitors: A New HIV Drug Class

POZ Exclusive: Jetsons-Era HIV Care and Prevention

Let’s take a quick look over some futuristic highlights from this year’s Conference on Retroviruses and Opportunistic Infections (CROI):

  • Risk of Transmitting HIV With Undetectable Viral Load = “Close to Zero”
  • There Are Big Benefits To Very Early Treatment
  • Genetically Modified Immune Cells May Be Possible
  • Possibiltiy of Long-Term Injectable ARVs?
  • Attachment Inhibitors: A New HIV Drug Class
Is ‘Undetectable’ the New ‘Negative’?
David Duran: “In a perfect world, everyone would get tested, know their status, and take the appropriate steps thereafter…
Having an undetectable viral load would be sexy. Knowing your status and getting tested regularly would be, well, regular. Being HIV positive and having an undetectable viral load would be considered the same thing as being HIV negative.”

Is ‘Undetectable’ the New ‘Negative’?

David Duran: “In a perfect world, everyone would get tested, know their status, and take the appropriate steps thereafter…

Having an undetectable viral load would be sexy. Knowing your status and getting tested regularly would be, well, regular. Being HIV positive and having an undetectable viral load would be considered the same thing as being HIV negative.”

Can There Be a Fourth Great Wave of AIDS Activism?Raymond Smith writes:

"The major new opportunity that has arisen recently has been encapsulated in the term "treatment as prevention." Powerful new evidence has emerged that ARVs not only can preserve the lives and the health of people with HIV but, by lowering their viral load, can significantly reduce the odds of new transmissions….Talk of ‘the end of AIDS’ has begun to feel, for the first time, like an attainable reality—but only if HIV/AIDS once again receives enough focus and energy.”

Can There Be a Fourth Great Wave of AIDS Activism?

Raymond Smith writes:


"The major new opportunity that has arisen recently has been encapsulated in the term "treatment as prevention." Powerful new evidence has emerged that ARVs not only can preserve the lives and the health of people with HIV but, by lowering their viral load, can significantly reduce the odds of new transmissions….

Talk of ‘the end of AIDS’ has begun to feel, for the first time, like an attainable reality—but only if HIV/AIDS once again receives enough focus and energy.”